Roche has rapidly developed additional testing options to differentiate mutations in the Omicron SARS-CoV-2 variant

by NASDAQ Market News December 3, 2021

NASDAQ Market News
Click here to email author

ARASENS trial with darolutamide in combination with docetaxel and androgen deprivation therapy meets primary endpoint of significantly increasing overall survival in patients with metastatic hormone-sensitive prostate cancer

HUTCHMED Announces Agreement with NHSA for Continued Inclusion of ELUNATE® and Addition of SULANDA® in the National Reimbursement Drug List in China

Ads